Evidence map›Paper›PMID 21269669›Full record

ArticleThe Journal of allergy and clinical immunology2011

Host and viral factors associated with severity of human rhinovirus-associated infant respiratory tract illness.

E Kathryn Miller, John V Williams, Tebeb Gebretsadik, Kecia N Carroll, William D Dupont, Yassir A Mohamed, Laura-Lee Morin, Luke Heil, Patricia A Minton, Kimberly Woodward and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of allergy and clinical immunology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
9.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 105 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Navigating paediatric virology through the COVID‑19 era (Review).International journal of molecular medicine · 2023
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Respiratory Viruses and Asthma.Seminars in respiratory and critical care medicine · 2018
    Review
  15. Article
  16. Article
  17. Article
  18. [An epidemiological study on human rhinovirus C in hospitalized children with respiratory tract infections].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2016
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

E Kathryn MillerDepartment of Pediatrics, Vanderbilt University, Nashville, TN 37232-8300, USA.
John V Williams
Tebeb Gebretsadik
Kecia N Carroll
William D Dupont
Yassir A Mohamed
Laura-Lee Morin
Luke Heil
Patricia A Minton
Kimberly Woodward
Zhouwen Liu
Tina V Hartert
Vanderbilt University · US

Funding

VANDERBILT UNIVERSITY CTSA FOR PEDIATRIC RESEARCHUL1RR024975 · NCRR · VANDERBILT UNIVERSITY · PI BERNARD, GORDON RAPHAEL · 2007 to 2011
$45.7M
The Population-Based Effectiveness in Asthma and Lung Diseases (PEAL) NetworkR01HS019669 · AHRQ · HARVARD PILGRIM HEALTH CARE, INC. · PI SOUMERAI, STEPHEN B · 2010 to 2010
$4.5M
Vanderbilt Environmental Health Science Scholars ProgramK12ES015855 · NIEHS · VANDERBILT UNIVERSITY · PI BROWN, NANCY J. · 2007 to 2011
$3.5M
The Vanderbilt Institute for Clinical and Translational Research (VICTR) KL2KL2RR024977 · NCRR · VANDERBILT UNIVERSITY · PI BERNARD, GORDON RAPHAEL · 2007 to 2011
$3.0M
Asthma Disparities in Cohorts at Risk for MorbidityU01HL072471 · NHLBI · VANDERBILT UNIVERSITY · PI SHELLER, JAMES R · 2002 to 2006
$2.9M
Midcareer Investigator Patient-oriented Research Award in Bronchiolitis & AsthmaK24AI077930 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI HARTERT, TINA V · 2008 to 2017
$1.6M
Tools to Reduce Infant RSV Morbidity and Asthma: Use, Adherence and EffectivenessR01HS018454 · AHRQ · VANDERBILT UNIVERSITY · PI HARTERT, TINA V · 2009 to 2011
$1.5M
The Vanderbilt Institute for Clinical and Translational Research (VICTR) TL1TL1RR024978 · NCRR · VANDERBILT UNIVERSITY · PI BERNARD, GORDON RAPHAEL · 2007 to 2011
$1.3M
Etiology and Severity of Infant Bronchiolitis and Development of Childhood AsthmaK01AI070808 · NIAID · VANDERBILT UNIVERSITY · PI CARROLL, KECIA NICOLE · 2007 to 2011
$623k
AHRQ HHS R01 HS018454AHRQ HHS R01 HS019669NCRR NIH HHS KL2 RR024977NCRR NIH HHS KL2 RR24977-03NCRR NIH HHS TL1 RR024978NCRR NIH HHS UL1 RR024975NHLBI NIH HHS L40 HL086298NHLBI NIH HHS U01 HL 072471NHLBI NIH HHS U01 HL072471NIAID NIH HHS K01 AI070808NIAID NIH HHS K24 AI 077930NIAID NIH HHS K24 AI077930NIAID NIH HHS R01 AI 05884NIEHS NIH HHS K12 ES 015855NIEHS NIH HHS K12 ES015855
6 · The paper itself

Abstract

backgroundRisk factors for severe human rhinovirus (HRV)-associated infant illness are unknown.

objectivesWe sought to examine the role of HRV infection in infant respiratory tract illness and assess viral and host risk factors for HRV-associated disease severity.

methodsWe used a prospective cohort of term, previously healthy infants enrolled during an inpatient or outpatient visit for acute upper or lower respiratory tract illness during the fall-spring months of 2004-2008. Illness severity was determined by using an ordinal bronchiolitis severity score, with higher scores indicating more severe disease. HRV was identified by means of real-time RT-PCR. The VP4/VP2 region from HRV-positive specimens was sequenced to determine species.

resultsOf 630 infants with bronchiolitis or upper respiratory tract illnesses (URIs), 162 (26%) had HRV infection; HRV infection was associated with 18% of cases of bronchiolitis and 47% of cases of URI. Among infants with HRV infection, 104 (64%) had HRV infection alone. Host factors associated with more severe HRV-associated illness included a maternal and family history of atopy (median score of 3.5 [interquartile range [IQR], 1.0-7.8] vs 2.0 [IQR, 1.0-5.2] and 3.5 [IQR, 1.0-7.5] vs 2.0 [IQR, 0-4.0]). In adjusted analyses maternal history of atopy conferred an increase in the risk for more severe HRV-associated bronchiolitis (odds ratio, 2.39; 95% CI, 1.14-4.99; P = .02). In a similar model maternal asthma was also associated with greater HRV-associated bronchiolitis severity (odds ratio, 2.49, 95% CI, 1.10-5.67; P = .03). Among patients with HRV infection, 35% had HRVA, 6% had HRVB, and 30% had HRVC.

conclusionHRV infection was a frequent cause of bronchiolitis and URIs among previously healthy term infants requiring hospitalization or unscheduled outpatient visits. Substantial viral genetic diversity was seen among the patients with HRV infection, and predominant groups varied by season and year. Host factors, including maternal atopy, were associated with more severe infant HRV-associated illness.

Indexed as

BronchiolitisCommon ColdFemaleHumansHypersensitivity, ImmediateInfantMaleMothersReverse Transcriptase Polymerase Chain ReactionRhinovirusRisk Factors

Identifiers

PMID21269669
PMCPMC3070861
OpenAlexW2125234583

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.